Freeline Receives Approval to Transfer to Nasdaq Capital Market

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference
Freeline Publishes Preclinical Proof-of-Concept Data for FLT190, its AAV Gene Therapy Candidate for Fabry Disease, in the Nature Journal Gene Therapy
Freeline Reports October 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freeline to participate at Conferences during January 2021
Freeline Therapeutics Updates Clinical Development Plan for its FLT180a Hemophilia B Program
Freeline To Participate In Conferences During January 2022
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels